Search results
Showing results for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
©
John Cairns
Oxford Open Grand Rounds
Oxford Open Grand Rounds
Leadership and Management in Healthcare
Leadership and Management in Healthcare
Becoming a Clinical Educator
Becoming a Clinical Educator
Human Factors, Teamwork, and Communication
Human Factors, Teamwork, and Communication
Quality Improvement Science and Systems Analysis
Quality Improvement Science and Systems Analysis
Healthcare Innovation and Technology
Healthcare Innovation and Technology
Fees and funding
Information about fees and funding opportunities available to applicants
Practice of Evidence-Based Healthcare
View the Practice of Evidence-Based Healthcare course on the Oxford Lifelong Learning website.
Practice of Evidence-Based Healthcare
View the Practice of Evidence-Based Healthcare course on the Oxford Lifelong Learning website.
Carcinoma in situ presented at EuropaDonna
Work on breast carcinoma in situ was discussed with members of the patient advocate organisation, EuropaDonna in October 2024.